Sana Biotechnology Inc (SANA) stock saw a decline, ending the day at $3.25 which represents a decrease of $-0.16 or -4.69% from the prior close of $3.41. The stock opened at $3.4 and touched a low of ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 45.04% ...

We recently compiled a list of the 10 Hottest Smid-Cap Stocks So Far In 2025. In this article, we are going to take a look at ...

As researchers push for a type 1 diabetes cure, Sana Biotechnology has provided a nudge forward with new, if limited, ...

Sana Biotechnology (SANA), a clinical-stage biotech company specializing in gene and cell therapies, has recently experienced significant moves in its stock performance, attracting investor attention.

Sana Biotechnology, Inc. stock will be surging today after the company showed it can safely administer its allogeneic cell therapy for diabetes to a patient with no immunosuppression. Engineered ...

Price Action: At the last check on Wednesday, SANA stock was up 263.60% at $6.01 during the premarket session.

With a supermajority of B2B buyers belonging to “digitally native” generations, it logically follows that the expectations of B2B buying have risen. Features like automated delivery tracking – ...

Sana stock is likely to correct downwards as the market prepares to wait years for more study data that could be used to support a formal approval submission," Ingham added.

Sana’s HIP technology aims to eliminate the ... In three months, CytomX Therapeutics’ stock has lost 14.5%. CTMX’s earnings beat estimates in two of the trailing four quarters and missed ...